Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Associated Ophthalmopathies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT07155668
What this trial is testing

A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 87
Post-approval studies (Phase 4)Study completedNCT01458600
What this trial is testing

Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)

Who this might be right for
Graves´ Disease
Mikael Lantz 65
Not applicableNot Yet RecruitingNCT07623837
What this trial is testing

Clinical Validation of AI-Based Quantitative Eye Movement Analysis From Smartphone 9-Gaze Videos (Glandy EOM)

Who this might be right for
Ocular Motility DisordersStrabismusExtraocular Muscle Dysfunction+1 more
THYROSCOPE INC. 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07462130
What this trial is testing

An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Nanjing Chia-tai Tianqing Pharmaceutical 74
Testing effectiveness (Phase 2)Looking for participantsNCT07547930
What this trial is testing

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TEDGraves OphthalmopathyGraves Orbitopathy
The First Affiliated Hospital of Xiamen University 8
Not applicableUnknownNCT04704414
What this trial is testing

Exophthalmometry With 3D Face Scanners

Who this might be right for
ExophthalmosGraves OphthalmopathyOrbital Tumor+1 more
University of Zurich 180
Testing effectiveness (Phase 2)WithdrawnNCT06087731
What this trial is testing

Efficacy and Safety of Tocilizumab for TAO

Who this might be right for
TocilizumabThyroid Associated Ophthalmopathy
Sun Yat-sen University
Not applicableStudy completedNCT02397109
What this trial is testing

MDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX)

Who this might be right for
Dysthyroid Ophthalmopathies
Fondation Ophtalmologique Adolphe de Rothschild 294
Testing effectiveness (Phase 2)Ended earlyNCT05394857
What this trial is testing

Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Patients

Who this might be right for
Active Moderate to Severe Graves' Orbitopathy
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 7
Not applicableUnknownNCT04096612
What this trial is testing

The Therapeutic Effect of Dysthyroid Optic Neuropathy

Who this might be right for
Thyroid Eye Disease
Sun Yat-sen University 20
Large-scale testing (Phase 3)UnknownNCT05015127
What this trial is testing

Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Who this might be right for
Thyroid Ophthalmopathy
Harbour BioMed (Guangzhou) Co. Ltd. 36
Not applicableStudy completedNCT05775185
What this trial is testing

Therapeutic Efficacy of Orbital Radiotherapy in Patients With Graves' Orbitopathy

Who this might be right for
Graves Ophthalmopathy
Medical University of Sofia 26
Post-approval studies (Phase 4)Looking for participantsNCT05126147
What this trial is testing

Hydroxychloroquine in Mild Graves' Orbitopathy

Who this might be right for
Graves Ophthalmopathy
National Taiwan University Hospital 108
Not applicableStudy completedNCT00348413
What this trial is testing

Thyroid Treatment Trial

Who this might be right for
Graves Ophthalmopathy
Singapore National Eye Centre 80
Not applicableStudy completedNCT06585592
What this trial is testing

Establishment of Multimodal-multiparametric Progressive Prediction Models for Thyroid Associated Ophthalmopathy

Who this might be right for
Thyroid-Associated Ophthalmopathy
Shanghai Changzheng Hospital 500
Large-scale testing (Phase 3)Study completedNCT06106828
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Hoffmann-La Roche 127
Large-scale testing (Phase 3)Study completedNCT06126783
What this trial is testing

A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TED
Innovent Biologics (Suzhou) Co. Ltd. 91
Not applicableStudy completedNCT01885533
What this trial is testing

Post-Radioiodine Graves' Management: The PRAGMA-Study

Who this might be right for
Graves' Disease
Newcastle-upon-Tyne Hospitals NHS Trust 803
Large-scale testing (Phase 3)Looking for participantsNCT06112340
What this trial is testing

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 75
Not applicableUnknownNCT05110040
What this trial is testing

Multi-model Image of Immunosuppressive Agents in TAO

Who this might be right for
Thyroid Associated Ophthalmopathy
Sun Yat-sen University 12
Next Page